Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lisa Takagi

 

Lisa is based in Tokyo as a managing editor and will be providing editorial coverage of all aspects of Japan’s prescription drug market for Scrip and the Pink Sheet, including company, market, pricing and regulatory developments, as well as helping to further expand our original content in the region through interviews and unique stories. In the longer term, the intention is for Lisa to support, along with the rest of the content team, our broader regional push towards more local-language content, use of multimedia, and thought leadership initiatives.

Lisa brings close to a decade of experience working in either international teams or reporting, writing and editing, including in broadcast media through an internship as a TV reporter in Canada. Most recently, she was covering another fast-moving, high-tech sector, IT, for ITmedia Enterprise in Japan, where several of her stories won quarterly “Best Content” awards and helped significantly expand readership.

Lisa holds an MA in Fine Art from Tokyo University of the Arts as well as a Master’s in Journalism from the University of King’s College in Halifax, Canada. She is native level bilingual in Japanese and English and also has conversational ability in Mandarin and French. Her interests and hobbies outside work include taking monochrome photos with digital/film cameras and visiting museums.

Latest From Lisa Takagi

Japan Passes New Economic Security Bill – What's The Pharma Impact?

Japan has passed a new law which will require the providers of certain products to cooperate in securing supplies to the country. For the pharma industry, there are a couple of signs which specific drugs will be within the scope of the legislation and how this will impact the sector.

Japan Policy

Mainstays Give And Take As Major Japan Firms Report Results

While Daiichi Sankyo reveals ambitious plan with Enhertu, Chugai shows stable growth plans with COVID-19 drugs, Astellas reacted to concerns over Xtandi’s slow growth with enthusiastic investment plan for the next potential star.

Japan Commercial

Lost In Translation? Japan’s GMP Compliance Dilemma

As Japan tightens regulations for good manufacturing practice, some members of the domestic pharma industry, including one inspector, are recognizing the need for official translations for foreign companies, which the ministry denied a year ago and continue to present challenges.

Japan Compliance

Japan Progresses 'Urgent Approval' System To Speed Drug Access

Japan is intending to revise existing pharma legislation to enable the urgent approval of new drugs with "assumed efficacy", with a maximum three-year period for confirmation, in cases of emergency need. The government will also ask companies to implement tighter safety monitoring and management of supply chains, with swift data disclosure required, as part of the planned changes.

Japan Drug Approval Standards

Arteryex Acquisition To Enhance Eisai's Digital Strategy

Eisai is acquiring Japanese software company Arteryex as part of a digital shift strategy, with the two companies to work together to develop and provide services around personal data, including health records.

Digital Health M & A

A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations

Japan struggles to recover its ever-expanding supply chain for generic drugs after several key players had their production stopped because of a series of GMP violations. As the share of generics grows under government policy, some in the industry argue the problems are deeply rooted in a decades-old pricing system.

Japan Generic Drugs
See All
UsernamePublicRestriction

Register